Prof. Andrew Kellett is a Professor of Inorganic and Medicinal Chemistry in the School of Chemical Sciences at Dublin City University (DCU). His research focuses on metallodrug-nucleic acid interactions, artificial gene editing, and therapeutic nucleic acids, situated at the intersection of synthetic chemistry and medicine.
Therapeutic Oligonucleotides for Cancer
Development of a modern generation of therapeutic oligonucleotides for targeting and destroying cancer at the genetic level.
Lead: Prof. Andrew Kellett
